tiprankstipranks
ALX Oncology to host virtual event to discuss Phase 1b/2 evorpacept data
PremiumThe FlyALX Oncology to host virtual event to discuss Phase 1b/2 evorpacept data
2M ago
Jazz Pharmaceuticals upgraded to Overweight from Equal Weight at Morgan Stanley
Premium
The Fly
Jazz Pharmaceuticals upgraded to Overweight from Equal Weight at Morgan Stanley
2M ago
Jazz upgraded to Overweight at Morgan Stanley after Ziihera launch
Premium
The Fly
Jazz upgraded to Overweight at Morgan Stanley after Ziihera launch
2M ago
FDA grants accelerated approval to Jazz Pharmaceuticals’ Ziihera
PremiumThe FlyFDA grants accelerated approval to Jazz Pharmaceuticals’ Ziihera
3M ago
Jazz Pharmaceuticals price target lowered to $163 from $166 at Piper Sandler
Premium
The Fly
Jazz Pharmaceuticals price target lowered to $163 from $166 at Piper Sandler
3M ago
Zymeworks, Jazz Pharmaceuticals announce FDA approval of Ziihera
Premium
The Fly
Zymeworks, Jazz Pharmaceuticals announce FDA approval of Ziihera
3M ago
Jazz Pharmaceuticals price target raised to $182 from $172 at BofA
PremiumThe FlyJazz Pharmaceuticals price target raised to $182 from $172 at BofA
4M ago
Jazz Pharmaceuticals price target lowered to $195 from $200 at TD Cowen
Premium
The Fly
Jazz Pharmaceuticals price target lowered to $195 from $200 at TD Cowen
4M ago
Jazz Pharmaceuticals price target lowered to $190 from $200 at Barclays
Premium
The Fly
Jazz Pharmaceuticals price target lowered to $190 from $200 at Barclays
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100